A Prospective Cohort Study of Radiotherapy Characteristics and Long-term Outcomes in Early Breast Cancer Omitting Sentinel Lymph Node Biopsy: The APROOB Cohort Study
This prospective, multicenter observational cohort study evaluates long-term outcomes in patients with early-stage invasive breast cancer who undergo breast-conserving surgery without sentinel lymph node biopsy or other axillary surgery and subsequently receive adjuvant radiotherapy. The study will evaluate recurrence, survival, radiotherapy-related toxicities, and quality of life. Radiotherapy will be delivered according to routine clinical practice at each participating institution without protocol-mandated treatment assignment. Detailed radiotherapy characteristics, including treatment volume, technique, dose and fractionation, tumor-bed boost, and radiation dose to axillary lymph node levels I-III, will be prospectively collected to evaluate their associations with clinical outcomes.
• Female patients aged 19 years or older with histologically confirmed invasive breast cancer
• Patients who have undergone breast-conserving surgery with curative intent
• Patients who did not undergo axillary lymph node surgery, including sentinel lymph node biopsy, at the time of breast cancer surgery
• No evidence of distant metastasis on clinical and imaging evaluation before surgery
• Planned to receive adjuvant radiotherapy after breast-conserving surgery
• Ability and willingness to provide written informed consent before study participation